T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Kirby Corp
KEX
$7.26B
| $36.9M | ﹤0.01% |
335,132
+2,173
| +0.7% | +$221K |
|
902
Kontoor Brands
KTB
$4.65B
| $36.8M | ﹤0.01% |
603,093
-35,918
| -6% | -$2.67M |
|
903
Lyft
LYFT
$6.48B
| $36.8M | ﹤0.01% |
1,898,121
+389,912
| +26% | +$8.1M |
|
904
Calix
CALX
$2.51B
| $36.4M | ﹤0.01% |
688,186
-545,040
| -44% | -$31.7M |
|
905
Grand Canyon Education
LOPE
$3.79B
| $36.4M | ﹤0.01% |
218,806
-438,790
| -67% | -$79.4M |
|
906
Green Brick Partners
GRBK
$3.04B
| $36.4M | ﹤0.01% |
580,108
+2,390
| +0.4% | +$158K |
|
907
Eversource Energy
ES
$27.2B
| $36.1M | ﹤0.01% |
536,242
+3,923
| +0.7% | +$275K |
|
908
Huron Consulting
HURN
$2.47B
| $36.1M | ﹤0.01% |
208,612
-11,391
| -5% | -$1.86M |
|
909
Ultragenyx Pharmaceutical
RARE
$2.6B
| $35.8M | ﹤0.01% |
1,554,366
-755,808
| -33% | -$24.9M |
|
910
NiSource
NI
$20.2B
| $35.7M | ﹤0.01% |
854,634
+7,605
| +0.9% | +$325K |
|
911
Devon Energy
DVN
$48.8B
| $35.5M | ﹤0.01% |
969,012
+30,591
| +3% | +$1.07M |
|
912
Sprouts Farmers Market
SFM
$7.71B
| $35.5M | ﹤0.01% |
445,301
+20,914
| +5% | +$1.88M |
|
913
Crane Co
CR
$12.7B
| $35.1M | ﹤0.01% |
190,534
-90,936
| -32% | -$16.9M |
|
914
American Eagle Outfitters
AEO
$2.73B
| $35M | ﹤0.01% |
1,329,109
+357,081
| +37% | +$7.06M |
|
915
Evergy
EVRG
$19.3B
| $35M | ﹤0.01% |
482,731
-72,707
| -13% | -$5.52M |
|
916
PTC Therapeutics
PTCT
$6.01B
| $35M | ﹤0.01% |
460,114
+1,784
| +0.4% | +$130K |
|
917
Allison Transmission
ALSN
$10.2B
| $34.9M | ﹤0.01% |
356,337
+3,757
| +1% | +$329K |
|
918
Casella Waste Systems
CWST
$5.79B
| $34.8M | ﹤0.01% |
355,623
-109,000
| -23% | -$10.1M |
|
919
SharkNinja
SN
$26.6B
| $34.6M | ﹤0.01% |
309,460
+44,027
| +17% | +$4.34M |
|
920
Ryman Hospitality Properties
RHP
$7.87B
| $34.5M | ﹤0.01% |
364,842
+3,093
| +0.9% | +$286K |
|
|
DAY
921
DELISTED
Dayforce
DAY
| $34.5M | ﹤0.01% |
498,277
-24,302,952
| -98% | -$1.67B |
|
922
Prestige Consumer Healthcare
PBH
$2.43B
| $34.5M | ﹤0.01% |
558,476
+10,611
| +2% | +$649K |
|
923
AngloGold Ashanti
AU
$48.1B
| $34.4M | ﹤0.01% |
403,743
+19,465
| +5% | +$1.52M |
|
924
Halliburton
HAL
$27.4B
| $34.4M | ﹤0.01% |
1,215,709
-4,627
| -0.4% | -$122K |
|
|
SION
925
Sionna Therapeutics
SION
$296M
| $34.2M | ﹤0.01% |
831,373
+193,613
| +30% | +$7.34M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.